Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial.
Raymond Y KwongBobak HeydariYin GeShuaib AbdullahKana FujikuraKyoichi KanekoWilliam S HarrisMichael Jerosch-HeroldElliott Marshall AntmanJonathan G SeidmanMarc A PfefferPublished in: PloS one (2019)
clinicaltrials.gov Identifier: NCT00729430.
Keyphrases
- fatty acid
- high dose
- acute myocardial infarction
- randomized controlled trial
- genome wide
- left ventricular
- study protocol
- low dose
- percutaneous coronary intervention
- stem cell transplantation
- dna methylation
- single cell
- heart failure
- clinical trial
- gene expression
- systematic review
- coronary artery disease
- atrial fibrillation